Manufacturers of Phenytoin formulations to include warning on serious skin reaction

The Central Drugs Standard Control Organization has directed State Drug Controllers and Union Territory to instruct manufacturers of Phenytoin formulations to include Acute Generalised Exanthematous Pustulosis, a potentially serious skin reaction, as an adverse drug reaction in the drugs’ package inserts and promotional literature, following safety signal assessments and expert committee recommendations.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.